Subscribe to our Email Alerts


Christopher Burns B.Sc. (Hons) PhD GAICD

Chief Executive Officer and Managing Director

Chris is an experienced drug discovery leader having worked in various roles in pharma, biotech and academia for 25 years. 

After completing a Ph D in Organic Chemistry at the University of Melbourne Chris undertook postodoctoral studies in the USA before moving to Pfizer UK, as a senior scientist. After 5 years he returned to Australia as a Research Fellow at the University of Sydney with the CRC for Molecular Engineering and Technology and after two years moved to the biotechnology company Ambri as Head of Chemistry. 

Chris then moved to the Melbourne-based biotech Cytopia as Head of Medicinal Chemistry and later as Research Director. Over this time he led teams in the discovery of two anti-cancer agents that have entered clinical trial, including the drug momelotinib which successfully completed Phase III studies. Chris was subsequently recruited to the Walter and Eliza Hall Institute of Medical Research in Melbourne as a Laboratory Head before taking on executive and leadership roles with a number of privately-held biotechnology companies in Melbourne including Certa Therapeutics and MycRx. 

Dr Burns is the inventor on over 30 patents and a co-author on over 60 scientific publications and is a Fellow of the Royal Society of Chemistry (UK) and the Royal Australian Chemical Institute. He was the recipient of the 2022 Adrien Albert Award - the premier award of the MCCB Division of the Royal Australian Chemical Institute which is given for sustained, outstanding research in the field of medicinal chemistry or chemical biology. 

Dr Burns was originally appointed as a Non-Executive Director on 4 May 2018 and was subsequently appointed as Chief Executive Officer and Managing Director on 5 December 2022. 


Rhiannon Jones BSC (Hons) PhD, GAICD

Chief Operating Officer

Rhiannon has a background in research operations and project management and more than 10 years of experience in the medical research and biotechnology sector. Rhiannon has previous appointments as Director, Operations and Governance (Cancer Therapeutics CRC), Project Manager (WEHI, Business Development Office), Scientific Coordinator (WEHI, Inflammation Division) and a postdoctoral researcher in organic chemistry (Monash University, Chemistry Department). Her experience includes project management, communications, policy development and oversight, ethics committee submissions, risk management and staff professional development systems.

Rhiannon has a PhD in chemistry and a BSc(Hons) from the University of Adelaide and a Certificate in Governance Practice from the Governance Institute of Australia and is a graduate of the AICD.

Hamish George CA , BCom, GIA(Cert)

Chief Financial Officer

Hamish is a Chartered Accountant and director at Bio101 Financial Advisory Pty Ltd, a financial services firm providing outsourced CFO, tax and company secretarial solutions to the life science sector.

Hamish is CFO and/or Company Secretary for numerous ASX listed and unlisted public and private companies. Hamish holds a Bachelor of Commerce from the University of Melbourne, a Masters Degree in Professional Accounting from RMIT and a Certificate in Governance Practice from the Governance Institute of Australia.

Hamish was appointed as Chief Financial Officer of Amplia Therapeutics Limited on 1 October 2021.

Andrew J. Cooke LL.B

Company Secretary

Andrew holds a law degree from Sydney University and has extensive experience in law, corporate finance, governance and compliance. He has over 30 years of boardroom experience and has developed a practical blend of legal and commercial acumen. He has served as a consultant to listed, public and private companies in the biotech, resources, property, mining services and technology sectors focussing on stock exchange, capital raisings, regulatory compliance and a wide range of corporate transactions. 

Andrew was appointed as Company Secretary of Amplia Therapeutics Limited on 11 October 2013.

Charlotte Mulder BVSc (Hons), MBA

Principal Development Manager

Charlotte has over ten years’ experience in drug development. Her early career as a Veterinarian in mixed practice in Australia and the UK was followed by a transition into veterinary clinical development with Pfizer Animal Health, then human drug development. Charlotte worked with Medicines Development for Global Health from 2011 until 2021, most recently in the role of Principal Development Manager and Project Leader. She has worked on a variety of projects at different stages of development, spanning preclinical through to regulatory approval. Her experience includes coordination of cross-functional development teams, stakeholder communication, management of international collaborative relationships, and strategic and technical input into development programs.  

Charlotte has a Bachelor of Veterinary Science (Hons) from the University of Melbourne and an MBA from Melbourne Business School.

Anthony Bishop BSc, GradDip

Principal Development Manager

Anthony has more than 25 years of experience in the commercial and operational elements of pharmaceutical development. Beginning at CSL as a production Scientist, Anthony progressed to Project Management Roles. On moving to Singapore, he project managed the first Asian central lab before moving to a business development role at Quintiles (now IQVIA) before leading the development of a new antibiotic through Phase 1 for Merlion Pharma. He helped found a biotech which went on to attract venture capital and moved to Malaysia to run the company. After 16 years in Asia, Anthony returned to Australia into a business development role with Quintiles before leading the development of a Phase 2 drug and then a whole genome diagnostic at genomiQa. His experience covers all aspects of global drug development and commercialisation from both the sponsor and CRO perspective.

Anthony has a Bachelor of Applied Science, Medical Laboratory Science from QUT and a Graduate Diploma of Manufacturing Management from RMIT.

Terrie-Anne Cock PhD

Head of Translational Biology

Terrie-Anne has over 18 years research and development experience, including with multinational pharmaceutical companies GlaxoSmithKline and OSI Pharmaceuticals. Her appointments include leadership roles as Senior Vice President, Therapeutic Research and Development at Microba Life Sciences; Director of Biology, Queensland Emory Drug Discovery Initiative; and, Director of Translational Research, Benitec Biopharma Limited. She has played key roles in the translation of molecules from research, through clinical trials, and regulatory approvals. This has included a diverse range of programs spanning novel, small molecules, biologics, live biotherapeutics, cell-based and gene-based therapies across multiple therapeutic areas.

Terrie-Anne undertook a postdoctoral fellowship, at the Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France and has a PhD in Medicine from University of New South Wales.

Adrian Sulistio B. Eng (Hons), B. Com, PhD

CMC Project Manager

Adrian has 15 years of experience in early research, process development and GMP manufacture within the life science and biotechnology industries. Prior to joining Amplia, Adrian held a role as Senior Development Scientist at PolyActiva, responsible for developing an ocular drug delivery implant from early-stage research all the way to clinical production. He is a co-inventor on five of patent families. Adrian also held several post-doctoral positions at Monash University and University of Melbourne working in numerous areas in polymer therapeutics, from drug delivery, cancer therapeutics, RNA delivery, antimicrobial polymers, and hydrogels scaffold formation.

Adrian has a Bachelor of Engineering (Chemical, Hons) and Commerce (Finance and Marketing) and a PhD in Polymer Chemistry from University of Melbourne.

Nicole Kruger BSc

Clinical Operations Manager

Nicole Kruger is contracted to Amplia as Clinical Operations Manager through her company NMK Consulting Services. Ms Kruger has almost 30 years’ experience in the biotechnology and pharmaceutical industry, with 25 in the clinical research field. Starting as a Clinical Trial Assistant and progressing through Clinical Research Associate, Project Manager and Operations Manager roles, she has worked with major pharmaceutical companies, Contract Research Organisations and medium to small biotechnology companies to implement and manage their clinical research programs and projects.